Superficial transitional cell carcinoma: bacillus Calmettedash;Gueacute;rin (BCG) and other intravesical agents

摘要

Adjuvant immunodash; andsol;or chemotherapy intravesically has become a standard at least for patients with intermediate or high risk for recurrence. Whereas in the past cystectomy was a firstdash;line therapy for patients with carcinomain situor highdash;grade T1 bladder tumor, radical surgery is today reserved for nondash;BCG responders or early recurrent disease. Curr Opin Urol 8:425ndash;429. copy; 1998 Lippincott Williams amp; Wilkins.